---
schema_version: "secwatch.filing_event.v1"
accession: "0000055529-24-000027"
form_type: "8-K"
ticker: "KEQU"
cik: "0000055529"
company_name: "KEWAUNEE SCIENTIFIC CORP /DE/"
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:31:21.262477+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kewaunee Scientific Q1 FY2025 sales down 2.9%, EPS $0.74 vs $0.86, backlog up 13%

## Summary
- Sales $48.4M, down 2.9% YoY; diluted EPS $0.74 vs $0.86 in prior year quarter.
- Domestic net earnings rose to $2.9M from $2.7M; International sales fell 10.7% due to India site delays.
- Order backlog grew to $159.4M from $140.8M a year ago (+13%).
- Adjusted EBITDA (excl. professional fees) $4.1M; professional fees unrelated to core business increased.
- Management sees strong backlog and quoting activity for another strong year.

## SEC filing metadata
- accession: 0000055529-24-000027
- form_type: 8-K
- ticker: KEQU
- cik: 0000055529
- company_name: KEWAUNEE SCIENTIFIC CORP /DE/
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/55529/000005552924000027/0000055529-24-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/55529/000005552924000027/kequ-20240911.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000055529-24-000027
- JSON: https://secwatch.observer/filing/0000055529-24-000027.json
- Plain text: https://secwatch.observer/filing/0000055529-24-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.